NeoVista, Inc. Raises $18 Million
NeoVista Inc., a Fremont, Calif.-based ophthalmic device company focused on the treatment of age-related macular degeneration, has raised $18 million in Series D funding. Return backers included Essex Woodlands Health Ventures, MPM Capital and return backers Versant Ventures, SV Life Sciences, The Carlyle Group and Accuitive Medical Ventures. NeoVista raised a $41 million Series C round in late 2006.